Inventor
MEVELLEC LAURENCE ANNE
FR30 patents
⚠️ This page may combine multiple inventors who share the name “MEVELLEC LAURENCE ANNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
17 patentsUS7196094B2Mar 27, 2007
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
JANSSEN PHARMACEUTICA NV11 citations84
US7173040B2Feb 6, 2007
Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derinazoline derivatives
JANSSEN PHARMACEUTICA NV21 citations84
US7803795B2Sep 28, 2010
Phthalazine derivatives as parp inhibitors
JANSSEN PHARMACEUTICA NV7 citations73
US7635706B2Dec 22, 2009
5HT4-antagonistic 4-(aminomethyl)-piperidine benzamides
JANSSEN PHARMACEUTICA NV2 citations62
US7652040B2Jan 26, 2010
Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists
JANSSEN PHARMACEUTICA NV5 citations61
US9598396B2Mar 21, 2017
Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
JANSSEN PHARMACEUTICA NV0 citations51
US9150540B2Oct 6, 2015
Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
JANSSEN PHARMACEUTICA NV1 citations51
US10894793B2Jan 19, 2021
Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors
JANSSEN PHARMACEUTICA NV0 citations48
US12492194B2Dec 9, 2025
HPK1 inhibitors
JANSSEN PHARMACEUTICA NV0 citations47
US12486264B2Dec 2, 2025
Bicyclic HPK1 inhibitors
JANSSEN PHARMACEUTICA NV0 citations47
US7638535B2Dec 29, 2009
4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists
JANSSEN PHARMACEUTICA NV0 citations41
US7732464B2Jun 8, 2010
Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists
JANSSEN PHARMACEUTICA NV0 citations40
US7498347B2Mar 3, 2009
Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4 antagonists
JANSSEN PHARMACEUTICA NV0 citations40
US10202387B2Feb 12, 2019
Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors
JANSSEN PHARMACEUTICA NV0 citations39
US10087187B2Oct 2, 2018
Imidazopyridazine derivatives as PI3KB inhibitors
JANSSEN PHARMACEUTICA NV0 citations39
US10280170B2May 7, 2019
Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitors
JANSSEN PHARMACEUTICA NV0 citations35
US10342795B2Jul 9, 2019
Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine derivatives and 2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives as ROS1 inhibitors
JANSSEN PHARMACEUTICA NV0 citations32